Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery

NCT ID: NCT06664710

Last Updated: 2025-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-17

Study Completion Date

2025-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the Automated Integration of a Robotics and ECochG System for Use with Cochlear Implant Surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate the feasibility and proof of concept of the integration of the AIM System and iotaSOFT Insertion System during cochlear implantation. Study results will help inform the need for future clinical investigations and data collection in the area of ECochG and robotic-assisted cochlear implantation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss, Sensorineural Cochlear Implantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Use of the iotaSOFT Insertion System and AIM based on Standard of Care

Group Type ACTIVE_COMPARATOR

iotaSOFT Insertion System with AIM Control

Intervention Type DEVICE

iotaSOFT Insertion System with AIM using standard of care insertion techniques

Experimental

Use of iotaSOFT Insertion System with AIM experimental device

Group Type EXPERIMENTAL

iotaSOFT Insertion System with AIM

Intervention Type DEVICE

Experimental subjects will receive the iotaSOFT Insertion System with AIM using robotic controlled stop

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iotaSOFT Insertion System with AIM

Experimental subjects will receive the iotaSOFT Insertion System with AIM using robotic controlled stop

Intervention Type DEVICE

iotaSOFT Insertion System with AIM Control

iotaSOFT Insertion System with AIM using standard of care insertion techniques

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Cochlear implant candidate in one or two ears per current FDA indications
2. Sufficient residual hearing to support use of electrocochleography, as determined by the investigator
3. Cochlear implantation using the Advanced Bionics SlimJ electrode array
4. 18 years of age or older at the time of enrollment
5. Willingness to participate in and comply with all requirements of the protocol

Exclusion Criteria

Contraindications for a CI. 2. Prior cochlear implantation in the ear to be implanted. 3. Cochlear ossification or malformation (including but not limited to dysplasia or common cavity), craniofacial abnormality or any other structural cochlear abnormality that might prevent complete insertion of the electrode array or present an increased risk of aberrant insertion.

4\. History of temporal bone fracture that involves the cochlea/internal auditory canal.

5\. Retrocochlear etiology (e.g. diagnosis of auditory neuropathy, cochlear nerve deficiency, or lesions of the acoustic nerve or central auditory pathway).

6\. Active middle-ear infection or tympanic membrane perforation in the presence of active middle ear disease.

7\. Planned or current participation in a clinical study of an investigational device or drug that may impact data collection or outcomes related to this investigation.

8\. Additional medical concerns that would prevent participation in evaluations as determined by the investigator.

9\. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the procedure and investigational device.

10\. Vulnerable subject, as per FDA regulations 21 CFR Parts 50 and 56
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

iotaMotion, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Iowa

Iowa City, Iowa, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Laura Chenier, Director of Clinical Affairs, AuD

Role: CONTACT

442-325-4171

Costa Nikou

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IAR2401

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP1110 Sound Processor Feasibility
NCT04898673 COMPLETED NA